SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: A meta-analysis of randomised controlled trials

BACKGROUND: Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been recommended in the practice guidelines for the treatment of patients with heart failure with reduced ejection fraction; however, their effects among patients with preserved ejection fraction have been debatable. OBJECTIVE: We a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaiswal, Akash, Jaiswal, Vikash, Ang, Song Peng, Hanif, Muhammad, Vadhera, Ananya, Agrawal, Vibhor, Kumar, Tushar, Nair, Anagha M., Borra, VamsikalyanReddy, Garimella, Vamsi, Ishak, Angela, Wajid, Zarghoona, Song, David, Attia, Abdelrahman M., Huang, Helen, Aguilera Alvarez, Victor Hugo, Shrestha, Abhigan Babu, Biswas, Monodeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545009/
https://www.ncbi.nlm.nih.gov/pubmed/37773799
http://dx.doi.org/10.1097/MD.0000000000034693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545009/
https://www.ncbi.nlm.nih.gov/pubmed/37773799
http://dx.doi.org/10.1097/MD.0000000000034693

Ejemplares similares